These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 2164639)

  • 1. bcr/abl and src but not myc and ras replace v-abl in lymphoid transformation.
    Engelman A; Rosenberg N
    Mol Cell Biol; 1990 Aug; 10(8):4365-9. PubMed ID: 2164639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of murine c-abl protooncogene: effect of a point mutation on oncogenic activation.
    Shore SK; Bogart SL; Reddy EP
    Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6502-6. PubMed ID: 2168550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An E mu-v-abl transgene elicits plasmacytomas in concert with an activated myc gene.
    Rosenbaum H; Harris AW; Bath ML; McNeall J; Webb E; Adams JM; Cory S
    EMBO J; 1990 Mar; 9(3):897-905. PubMed ID: 2155783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine kinase oncogenes abrogate interleukin-3 dependence of murine myeloid cells through signaling pathways involving c-myc: conditional regulation of c-myc transcription by temperature-sensitive v-abl.
    Cleveland JL; Dean M; Rosenberg N; Wang JY; Rapp UR
    Mol Cell Biol; 1989 Dec; 9(12):5685-95. PubMed ID: 2555703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structures and activities of activated abl oncogenes.
    Risser R; Holland GD
    Curr Top Microbiol Immunol; 1989; 147():129-53. PubMed ID: 2695292
    [No Abstract]   [Full Text] [Related]  

  • 6. Philadelphia chromosome-positive leukaemia: the translocated genes and their gene products.
    Allen PB; Morgan GJ; Wiedemann LM
    Baillieres Clin Haematol; 1992 Oct; 5(4):897-930. PubMed ID: 1308169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abelson virus abrogation of interleukin-3 dependence in a lymphoid cell line.
    Mathey-Prevot B; Nabel G; Palacios R; Baltimore D
    Mol Cell Biol; 1986 Nov; 6(11):4133-5. PubMed ID: 3025637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temperature-sensitive mutants of Abelson murine leukemia virus deficient in protein tyrosine kinase activity.
    Engelman A; Rosenberg N
    J Virol; 1990 Sep; 64(9):4242-51. PubMed ID: 1696637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of A-MuLV transformed fibroblast lines for amplification of the c-myc, p53 and c-fos nuclear proto-oncogenes.
    Colledge WH; Gebhardt A; Edge MD; Bell JC
    Oncogene; 1989 Jun; 4(6):753-7. PubMed ID: 2543944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl.
    Jackson P; Baltimore D
    EMBO J; 1989 Feb; 8(2):449-56. PubMed ID: 2542016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of p21 RAS in p210 bcr-abl transformation of murine myeloid cells.
    Mandanas RA; Leibowitz DS; Gharehbaghi K; Tauchi T; Burgess GS; Miyazawa K; Jayaram HN; Boswell HS
    Blood; 1993 Sep; 82(6):1838-47. PubMed ID: 7691239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene.
    Shtivelman E; Lifshitz B; Gale RP; Roe BA; Canaani E
    Cell; 1986 Oct; 47(2):277-84. PubMed ID: 3021337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the abl oncogene and its involvement in chromosomal translocations in human leukemia.
    Rosson D; Reddy EP
    Mutat Res; 1988 May; 195(3):231-43. PubMed ID: 3129652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conservation of function of Drosophila melanogaster abl and murine v-abl proteins in transformation of mammalian cells.
    Holland GD; Henkemeyer MJ; Kaehler DA; Hoffmann FM; Risser R
    J Virol; 1990 May; 64(5):2226-35. PubMed ID: 2157882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential control of muscle-specific gene expression specified by src and myc oncogenes in myogenic cells.
    Falcone G; Gauzzi MC; Tatò F; Alemà S
    Ciba Found Symp; 1990; 150():250-8; discussion 258-61. PubMed ID: 2115425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein.
    Pendergast AM; Quilliam LA; Cripe LD; Bassing CH; Dai Z; Li N; Batzer A; Rabun KM; Der CJ; Schlessinger J
    Cell; 1993 Oct; 75(1):175-85. PubMed ID: 8402896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.
    Kamps MP; Sefton BM
    Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumorigenic activity of the BCR-ABL oncogenes is mediated by BCL2.
    Sánchez-García I; Grütz G
    Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5287-91. PubMed ID: 7777499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temperature-sensitive transformation by an Abelson virus mutant encoding an altered SH2 domain.
    Mainville CA; Parmar K; Unnikrishnan I; Gong L; Raffel GD; Rosenberg N
    J Virol; 2001 Feb; 75(4):1816-23. PubMed ID: 11160680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenes. The beginning of the molecular description of a cancer.
    Baltimore D
    Cell Biophys; 1986 Dec; 9(1-2):17-31. PubMed ID: 2436791
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.